Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study

Table 1

Characteristics of 47 patients with severe CP who were treated with allogeneic UCBSCs.

Variables	Values
Mean age (SD), y	5.85 (6.12)
Age ranges (<10 y/≥10 y)	35/12
Gender
Male (%)	35 (74.5)
Female (%)	12 (25.5)
Duration of treatment (SD), d	27.17 (8.03)
Number of infusions (SD),	5.38 (1.36)
Birth method
Vaginal (%)	28 (59.6)
Cesarean (%)	19 (40.4)
Mean birth weight (SD), kg	2.53 (0.84)
Low birth weight (BW <3000 g) (%)	20 (42.6)
Mean gestational age (SD), w	35.06 (5.18)
Neonatal jaundice (%)	8 (17.0)
NHIE (%)	28 (59.6)
Epilepsy (%)	13 (27.7)
MIDP (%)	16 (34.0)

Note. NHIE: neonatal hypoxic ischemic encephalopathy; MIDP: mother infected during pregnancy; SD: standard deviation; y: year; kg: kilogram; w: week; d: day; : time.